Erasca
$9.99
56
-$0.15-1.48% Tuesday 20:00
Statistics
Day High
10.4
Day Low
9.77
52W High
22.47
52W Low
1.08
Volume
4,412,498
Avg. Volume
-
Mkt Cap
2.83B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.104291
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-323.3MNet Income
Analyst Ratings
21.71Average Price Target
The highest estimate is 30.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ERAS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap178B
Gilead Sciences
GILD
Mkt Cap163.4B
Merck
MRK
Mkt Cap277.02B
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Novartis
NVS
Mkt Cap279.67B
Pfizer
PFE
Mkt Cap149.77B
Roche
RHHBY
Mkt Cap328.49B
Array Technologies
ARRY
Mkt Cap1.2B
About
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
Show more...
CEO
Dr. Jonathan E. Lim M.D.
Employees
103
Country
United States
ISIN
US29479A1088
Listings
0 Comments
Share your thoughts
FAQ
What is Erasca stock price today?▼
The current price of ERAS is $9.99 USD — it has decreased by -1.48% in the past 24 hours. Watch Erasca stock price performance more closely on the chart.
What is Erasca stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Erasca stocks are traded under the ticker ERAS.
Is Erasca stock price growing?▼
ERAS stock has risen by +9.66% compared to the previous week, the month change is a -41.65% fall, over the last year Erasca has showed a +699.2% increase.
What is Erasca market cap?▼
Today Erasca has the market capitalization of 2.83B
When is the next Erasca earnings date?▼
Erasca is going to release the next earnings report on May 07, 2026.
What were Erasca earnings last quarter?▼
ERAS earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.11 USD resulting in a +6.54% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Erasca revenue for the last year?▼
Erasca revenue for the last year amounts to 0 USD.
What is Erasca net income for the last year?▼
ERAS net income for the last year is -323.3M USD.
How many employees does Erasca have?▼
As of May 06, 2026, the company has 103 employees.
In which sector is Erasca located?▼
Erasca operates in the Health & Wellness sector.
When did Erasca complete a stock split?▼
Erasca has not had any recent stock splits.
Where is Erasca headquartered?▼
Erasca is headquartered in San Diego, United States.